These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 1462276)

  • 1. Relationship between the immune system and the diseases of the central nervous system.
    Bokor M; Faragó A; Schnabel R; Garam T
    Ther Hung; 1992; 40(2):51-7. PubMed ID: 1462276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunological status in Parkinson's disease.
    Fiszer U; Piotrowska K; Korlak J; Członkowska A
    Med Lab Sci; 1991 Jul; 48(3):196-200. PubMed ID: 1787777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody-dependent cell-mediated cytotoxicity (ADCC) in Parkinson's disease.
    Bokor M; Faragó A; Garam T; Malatinszky G; Schnabel R
    J Neurol Sci; 1993 Mar; 115(1):47-50. PubMed ID: 8468591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer cells of Parkinson's disease patients are set up for activation: a possible role for innate immunity in the pathogenesis of this disease.
    Mihara T; Nakashima M; Kuroiwa A; Akitake Y; Ono K; Hosokawa M; Yamada T; Takahashi M
    Parkinsonism Relat Disord; 2008; 14(1):46-51. PubMed ID: 17702627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia.
    Stoffers D; Bosboom JL; Deijen JB; Wolters EC; Berendse HW; Stam CJ
    Brain; 2007 Jul; 130(Pt 7):1847-60. PubMed ID: 17412733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features of 35 patients with Parkinson's disease displaying REM behavior disorder.
    Ozekmekçi S; Apaydin H; Kiliç E
    Clin Neurol Neurosurg; 2005 Jun; 107(4):306-9. PubMed ID: 15885389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immune factors or depression? Fatigue correlates in Parkinson's disease].
    Katsarou Z; Bostantjopoulou S; Hatzizisi O; Giza E; Soler-Cardona A; Kyriazis G
    Rev Neurol; 2007 Dec 16-31; 45(12):725-8. PubMed ID: 18075986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ropinirole in the treatment of early Parkinson's disease: a 6-month interim report of a 5-year levodopa-controlled study. 056 Study Group.
    Rascol O; Brooks DJ; Brunt ER; Korczyn AD; Poewe WH; Stocchi F
    Mov Disord; 1998 Jan; 13(1):39-45. PubMed ID: 9452324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.
    Holloway RG; Shoulson I; Fahn S; Kieburtz K; Lang A; Marek K; McDermott M; Seibyl J; Weiner W; Musch B; Kamp C; Welsh M; Shinaman A; Pahwa R; Barclay L; Hubble J; LeWitt P; Miyasaki J; Suchowersky O; Stacy M; Russell DS; Ford B; Hammerstad J; Riley D; Standaert D; Wooten F; Factor S; Jankovic J; Atassi F; Kurlan R; Panisset M; Rajput A; Rodnitzky R; Shults C; Petsinger G; Waters C; Pfeiffer R; Biglan K; Borchert L; Montgomery A; Sutherland L; Weeks C; DeAngelis M; Sime E; Wood S; Pantella C; Harrigan M; Fussell B; Dillon S; Alexander-Brown B; Rainey P; Tennis M; Rost-Ruffner E; Brown D; Evans S; Berry D; Hall J; Shirley T; Dobson J; Fontaine D; Pfeiffer B; Brocht A; Bennett S; Daigneault S; Hodgeman K; O'Connell C; Ross T; Richard K; Watts A;
    Arch Neurol; 2004 Jul; 61(7):1044-53. PubMed ID: 15262734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of sera of breast cancer patients on NK cell activity].
    Konjević G; Spuzić I
    Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship between weight loss and dysphagia in patients with Parkinson's disease].
    Nozaki S; Saito T; Matsumura T; Miyai I; Kang J
    Rinsho Shinkeigaku; 1999 Oct; 39(10):1010-4. PubMed ID: 10655760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Controlled release levodopa-benserazide and changes in efficacy during treatment of Parkinson's disease].
    Rondot P; Ziegler M; Aymard N; Holzer J
    Rev Neurol (Paris); 1987; 143(11):746-52. PubMed ID: 3324265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relation between autonomic dysfunction and progression of Parkinson's disease].
    Oka H; Mochio S; Inoue K
    Rinsho Shinkeigaku; 2001 Jun; 41(6):283-8. PubMed ID: 11771156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinson disease with old-age onset: a comparative study with subjects with middle-age onset.
    Diederich NJ; Moore CG; Leurgans SE; Chmura TA; Goetz CG
    Arch Neurol; 2003 Apr; 60(4):529-33. PubMed ID: 12707066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of levodopa on interleukin-15 and RANTES circulating levels in patients affected by Parkinson's disease.
    Gangemi S; Basile G; Merendino RA; Epifanio A; Di Pasquale G; Ferlazzo B; Nicita-Mauro V; Morgante L
    Mediators Inflamm; 2003 Aug; 12(4):251-3. PubMed ID: 14514477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multivariate analysis of the problems of long-term levodopa therapy in Parkinson's disease].
    Nakamura Y; Yoshinaga J; Endo S; Hikiji A
    Rinsho Shinkeigaku; 1997 Jun; 37(6):469-75. PubMed ID: 9366172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of non-steroidal anti-inflammatory drugs on natural killer cell activity in patients with dementia.
    Aizen E; Kagan G; Assy B; Iobel R; Bershadsky Y; Gilhar A
    Isr Med Assoc J; 2005 Feb; 7(2):78-81. PubMed ID: 15729955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Startling facts about emotion in Parkinson's disease: blunted reactivity to aversive stimuli.
    Bowers D; Miller K; Mikos A; Kirsch-Darrow L; Springer U; Fernandez H; Foote K; Okun M
    Brain; 2006 Dec; 129(Pt 12):3356-65. PubMed ID: 17095520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis of Parkinson's disease: time to stage III, IV, V, and to motor fluctuations.
    Sato K; Hatano T; Yamashiro K; Kagohashi M; Nishioka K; Izawa N; Mochizuki H; Hattori N; Mori H; Mizuno Y;
    Mov Disord; 2006 Sep; 21(9):1384-95. PubMed ID: 16763980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.